Prmt inhibitor compounds and the uses thereof
AssigneePurdue Research Foundation
InventorsRong HUANG, Youchao DENG
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds for inhibiting PRMT activity, methods of treatment for conditions exhibiting abnormal or dysfunctional PRMT activity. The invention described herein also pertains to pharmaceutical compositions and methods for treating diseases in mammals using those compounds disclosed herein.
Claims64
A compound having a formula (I):
- or a pharmaceutically acceptable salt thereof, wherein:
- X is a N or S,
- n is an integer from 1-12;
- and
- Y is NRp or O, wherein Rp is H or a protecting group, and
- Z1 is N or CH, and
- Z2 is O or CH2, and
- R1 is an acyl, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, cycloalkyl, heterocyloalkyl, cycloalkenyl, heterocycloakenyl, heterocyclyl, or an optionally substituted aryl, arylalkyl, or arylalkenyl, and
- R2 is an H or an acyl, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, cycloalkyl, heterocyloalkyl, cycloalkenyl, heterocycloakenyl, heterocyclyl, or an optionally substituted aryl, arylalkyl, arylalkenyl or aryalkynyl.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A compound having the formula (III), wherein the compound has the formula (III):
- or a pharmaceutically acceptable salt thereof,
- wherein:
- each n is independently an integer from 1-12;
- and
- Y and Z are either NH or O, and
- R1 is an acyl, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, cycloalkyl, heterocyloalkyl, cycloalkenyl, heterocycloakenyl, heterocyclyl, or an optionally substituted aryl, arylalkyl, or arylalkenyl, and
- R2 is an H or an acyl, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, cycloalkyl, heterocyloalkyl, cycloalkenyl, heterocycloakenyl, heterocyclyl, or an optionally substituted aryl, arylalkyl, arylalkenyl or aryalkynyl, and
- R3 is an acyl, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, cycloalkyl, heterocyloalkyl, cycloalkenyl, heterocycloakenyl, heterocyclyl, or an optionally substituted aryl, arylalkyl, or arylalkenyl.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A compound of the formula:
- or pharmaceutically acceptable salt thereof.
A compound of the formula:
- or a pharmaceutically acceptable salt thereof, wherein:
- X is a N or S,
- X′ is a NH, S or O,
- n is an integer from 1-12;
- and
- Y is NRp or O, wherein Rp is H or a protecting group, and
- Z1 is N or CH, and
- Z2 is O or CH2, and
- each R1 is, independently, an acyl, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, cycloalkyl, heterocyloalkyl, cycloalkenyl, heterocycloakenyl, heterocyclyl, or an optionally substituted aryl, arylalkyl, or arylalkenyl, and
- R2 is an H or an acyl, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, cycloalkyl, heterocyloalkyl, cycloalkenyl, heterocycloakenyl, heterocyclyl, or an optionally substituted aryl, arylalkyl, arylalkenyl or aryalkynyl.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.